Using Economic Evaluations to Make Formulary Coverage Decisions: So Much for Guidelines

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.1, 2000-07, pp. : 55-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using Pharmacoeconomic Analysis to Make Drug Insurance Coverage Decisions

By Anis A.H. Rahman T. Schechter M.T.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 119-126

Adis International

Access to resources Recommend Favorite

Reassessing the Relevance of Pharmacoeconomic Analyses in Formulary Decisions

By Johnson J.A.

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 479-485

Adis International

Access to resources Recommend Favorite

Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference?

By Goeree R.

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 561-572

Adis International

Access to resources Recommend Favorite

Analysis Sans Frontières: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?

By Sculpher Mark J. Drummond Michael F.

PharmacoEconomics, Vol. 24, Iss. 11, 2006-01 ,pp. : 1087-1099

Adis International

Access to resources Recommend Favorite

Anticancer drug coverage decisions evaluated

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 606, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite